VladCRadulescuMDMedical Director, Ped. Hem. Onc.(He/Him)
Pediatric Hematology & Oncology • Lexington, KYPediatric Coagulation Disorder Hematology
Professor of Pediatrics
Dr. Radulescu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Rose St
# Kentucky
Lexington, KY 40536Phone+1 859-323-5481Fax+1 859-257-7706
Summary
- Dr. Vlad Radulescu is a pediatric hematologist/oncologist in Lexington, KY and is affiliated with multiple hospitals in the area, including UK HealthCare Good Samaritan Hospital and University of Kentucky Albert B. Chandler Hospital. He received his medical degree from Carol Davila University of Medicine and Pharmacy and has been in practice 27 years. He specializes in pediatric coagulation disorder hematology.
Education & Training
Icahn School of Medicine at Mount Sinai/Kravis Children'sFellowship, Pediatric Hematology/Oncology, 1997 - 2000
Stony Brook Medicine/University HospitalResidency, Pediatrics, 1994 - 1997
Carol Davila University of Medicine and PharmacyClass of 1990
Certifications & Licensure
NY State Medical License 2000 - Present
KY State Medical License 2002 - 2025
TN State Medical License 2000 - 2006
FL State Medical License 2000 - 2002
PA State Medical License 1997 - 2000- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Hemophilia Inhibitor Previously Untreated Patient Study Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 40 citationsImpact of obesity on the risk of venous thromboembolism in an inpatient pediatric population.Sean M. Stokes, Patrick Breheny, Aurelia Radulescu, Vlad C. Radulescu
Pediatric Hematology and Oncology. 2014-07-23 - 22 citationsBleeding symptoms and laboratory correlation in patients with severe von Willebrand disease.Ara Metjian, C. Wang, Suman L. Sood, Adam Cuker, S. M. Peterson
Haemophilia. 2009-07-10 - 41 citationsRurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study.Robert Klamroth, Jerzy Windyga, Vlad C. Radulescu, Peter William Collins, Oleksandra Stasyshyn
Blood. 2021-04-01
Press Mentions
‘Life or Death’: The Impact of Blood Donations Across UK HealthCareSeptember 11th, 2024
Other Languages
- Romanian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
